Atea Pharmaceuticals (AVIR) announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors. Kirsch is currently a Senior Advisor with Alvarez & Marsal’s Life Sciences Industry Group.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVIR: